Vorinostat Completed Phase 1 Trials for Localized Unresectable Neuroblastoma / Stage 4 Neuroblastoma / Recurrent Neuroblastoma / Stage 4S Neuroblastoma / Regional Neuroblastoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01208454Vorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent Neuroblastoma